334 related articles for article (PubMed ID: 34420885)
1. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.
Liu YX; Liu X; Cen C; Li X; Liu JM; Ming ZY; Yu SF; Tang XF; Zhou L; Yu J; Huang KJ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):409-415. PubMed ID: 34420885
[TBL] [Abstract][Full Text] [Related]
2. Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.
Huang G; Jin Q; Mao Y
J Med Internet Res; 2023 Sep; 25():e46891. PubMed ID: 37698911
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
4. Machine-Learning Algorithm for Predicting Fatty Liver Disease in a Taiwanese Population.
Chen YY; Lin CY; Yen HH; Su PY; Zeng YH; Huang SP; Liu IL
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887527
[TBL] [Abstract][Full Text] [Related]
5. Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults.
Qin S; Hou X; Wen Y; Wang C; Tan X; Tian H; Ao Q; Li J; Chu S
Sci Rep; 2023 Mar; 13(1):3638. PubMed ID: 36869105
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of machine learning models for nonalcoholic fatty liver disease.
Peng HY; Duan SJ; Pan L; Wang MY; Chen JL; Wang YC; Yao SK
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):615-621. PubMed ID: 37005147
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study.
Cao T; Zhu Q; Tong C; Halengbieke A; Ni X; Tang J; Han Y; Li Q; Yang X
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1456-1466. PubMed ID: 38508988
[TBL] [Abstract][Full Text] [Related]
8. Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn's disease in Chinese population.
Mao J; Chao K; Jiang FL; Ye XP; Yang T; Li P; Zhu X; Hu PJ; Zhou BJ; Huang M; Gao X; Wang XD
World J Gastroenterol; 2023 Jun; 29(24):3855-3870. PubMed ID: 37426324
[TBL] [Abstract][Full Text] [Related]
9. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population.
Yip TC; Ma AJ; Wong VW; Tse YK; Chan HL; Yuen PC; Wong GL
Aliment Pharmacol Ther; 2017 Aug; 46(4):447-456. PubMed ID: 28585725
[TBL] [Abstract][Full Text] [Related]
10. A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.
Qian Y; Sun B; Zhang Y; Zhang M; Jiao X; Lai L; Yang W
Ann Palliat Med; 2022 Jul; 11(7):2349-2359. PubMed ID: 35542976
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.
Pan H; Liu B; Luo X; Shen X; Sun J; Zhang A
Lipids Health Dis; 2023 Nov; 22(1):205. PubMed ID: 38007441
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Nonalcoholic Fatty Liver Disease by Anthropometric Indices and Bioelectrical Impedance Analysis in Children.
Lee LW; Yen JB; Lu HK; Liao YS
Child Obes; 2021 Dec; 17(8):551-558. PubMed ID: 34265208
[No Abstract] [Full Text] [Related]
13. Establishment of noninvasive diabetes risk prediction model based on tongue features and machine learning techniques.
Li J; Chen Q; Hu X; Yuan P; Cui L; Tu L; Cui J; Huang J; Jiang T; Ma X; Yao X; Zhou C; Lu H; Xu J
Int J Med Inform; 2021 May; 149():104429. PubMed ID: 33647600
[TBL] [Abstract][Full Text] [Related]
14. Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China.
Ma H; Xu CF; Shen Z; Yu CH; Li YM
Biomed Res Int; 2018; 2018():4304376. PubMed ID: 30402478
[TBL] [Abstract][Full Text] [Related]
15. Predicting Fetal Alcohol Spectrum Disorders Using Machine Learning Techniques: Multisite Retrospective Cohort Study.
Oh SS; Kuang I; Jeong H; Song JY; Ren B; Moon JY; Park EC; Kawachi I
J Med Internet Res; 2023 Jul; 25():e45041. PubMed ID: 37463016
[TBL] [Abstract][Full Text] [Related]
16. Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLD.
Feng G; Zheng KI; Li YY; Rios RS; Zhu PW; Pan XY; Li G; Ma HL; Tang LJ; Byrne CD; Targher G; He N; Mi M; Chen YP; Zheng MH
J Hepatobiliary Pancreat Sci; 2021 Jul; 28(7):593-603. PubMed ID: 33908180
[TBL] [Abstract][Full Text] [Related]
17. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
Hu H; Han Y; Cao C; He Y
J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
[TBL] [Abstract][Full Text] [Related]
18. Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease.
Yang M; Jiang L; Wang Y; Li X; Zou Z; Han T; Nan Y; Lu F; Zhao J
J Gastrointestin Liver Dis; 2019 Sep; 28(3):289-296. PubMed ID: 31517325
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.
Sharma D; Gotlieb N; Farkouh ME; Patel K; Xu W; Bhat M
J Am Heart Assoc; 2022 Jan; 11(1):e022576. PubMed ID: 34927450
[TBL] [Abstract][Full Text] [Related]
20. Digital image analysis of ultrasound images using machine learning to diagnose pediatric nonalcoholic fatty liver disease.
Das A; Connell M; Khetarpal S
Clin Imaging; 2021 Sep; 77():62-68. PubMed ID: 33647632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
